Cannabis Pioneer Calvin Frye Join Gala Global, Inc. Advisory Board
LOS ANGELES, CA / ACCESSWIRE / July 7, 2015 / Gala Global, Inc. (PINKSHEETS: GLAG) is pleased to announce a signed management and service contract under its wholly owned subsidiary Cannabis Ventures. Cannabis Ventures recently signed a management contract with an Ontario Canada based operation to manage the business affairs and provide comprehensive service. Cannabis Venture will assist the client regarding equipment and installation services for their final application review process with Health Canada for the Marijuana for Medical Purposes Regulations (MMPR) license. Cannabis Venture also signed initial management service agreement with California Dispensary operations, Compassionate Caregivers. Compassionate Caregiver was one of the first approved legal dispensary in the United States.
Cannabis Ventures, Inc will work with GreenGro Technologies' (PINKSHEETS:GRNH) Vertical Hydrogarden subsidiary to supply the modular Grow Rooms and additional equipment support required for the project including equipment sourcing and technology applications. Greengro will also extend their expertise related to indoor and outdoor agricultural science systems and techniques for implementing medical marijuana plant growth systems consulting in key areas such as structure and interior design.
Mr. Calvin Frye, a seasoned cannabis pioneer, dispensary owner, and industry consultant joins the Gala Global' advisory board. Mr. Frye has significant experience in the biotech industry having worked with Xoma, Amgen and Baxter Biosciences. He has over a decade of experience in the cannabis industry and considers himself a pioneer in the movement. In 2005, he opened one of the first legal dispensaries in the United States. Mr. Frye has helped get legislation passed to make State recreational or medical cannabis legal in WA, OR and CO. Mr. Frye has extensive knowledge of the regulatory issues within this industry resulting from his experience working with the LA City Council, the Mayor and the LAPD. Mr. Frye has also branded his own line of cannabis genetics and trademarked the name "Cloneville" which he has attached to his genetics. This is very important in establishing a successful Brand. Mr. Frye owns Frye Consulting and Management Group, which provides consulting services for startup to full scale production facilities, including regulatory expertise. Mr. Frye also employs a tribal attorney who has vast experience of working with Indian Reservations and the Federal Government. Mr. Frye earned his Bachelor of Science degree from the University of Iowa in Science Education. He also attended graduate school with an emphasis in General Science.
Drew Milburn, CEO of Gala Global stated, "We continue to advance the business divisions along with adding industry expertise to our Gala Global team. We are excited to have Mr. Frye's involvement with his vast knowledge and industry experience in accomplishing Gala Global's mission and in expanding our vision."
Calvin Frye stated, "Our expertise is in genetics. My passion is to the patient who is in need of a quality product. Cloneville is thankful to have this opportunity with Gala Global. Cloneville is setting the standard for genetics along with the new surge in entrepreneurship in the cannabis industry. It is really cool to be able to help and to participate in new opportunities and territories."
About Gala Global, Inc.
GALA Global, Inc. (PINKSHEETS:GLAG) is a publicly traded development stage company which plans to expand in the Hemp and Cannabis industries. The Company is refocusing its purpose on the development, research, and commercialization of products derived from Hemp and Cannabis Plant, while expanding the clothing operations and upcoming Hemp based fiber apparel and accessories division.
For more information, visit www.galaglobalinc.com
For more information, visit www.cbdlivin.com
For more information, visit www.cannabisventuresinc.com
About Cannabis Ventures, Inc.
Cannabis Ventures (CVI) was organized for the purpose of developing leading scientific processing to cultivate a bio-medical grade Cannabis plant featuring a higher concentration Cannabidiol (CBD) value with natural healing powers. The team along with expert consultants which have specific expertise in pharmaceutical sciences (medicinal chemistry of natural products) and herbal pharmacology. Cannabis Ventures plans to supply the medical marijuana market along with alternate medicinal supply for global market for highly enriched plant concentration of Cannabidiol.
About Greengro Technologies
Greengro Technologies (PINKSHEETS: GRNH) is a world class provider of eco-friendly green technologies with specific domain expertise in indoor and outdoor agricultural science systems serving both the consumer and commercial farming markets. It brings together community and commerce through the growth and distribution of healthy, nutritious foods and vital medicines backed by science and technology. Customers include restaurants, community gardens, small and large scale commercial clients. Greengro Technologies also provides design, construction and maintenance services to large grow and cultivation operations and collectives in the medical and recreational marijuana sectors.
The company's websites www.greengrotech.com, www.bpgardens.com and www.verticalhydrogarden.com.
Disclaimer: The Company relies upon the Safe Harbor Laws of 1933, 1934 and 1995 for all public news releases. Statements, which are not historical facts, are forward-looking statements. The company, through its management, makes forward-looking public statements concerning its expected future operations, performance and other developments. Such forward-looking statements are necessarily estimates reflecting the company's best judgment based upon current information and involve a number of risks and uncertainties, and there can be no assurance that other factors will not affect the accuracy of such forward-looking statements. It is impossible to identify all such factors. Factors which could cause actual results to differ materially from those estimated by the company include, but are not limited to, government regulation; managing and maintaining growth; the effect of adverse publicity; litigation; competition; and other factors which may be identified from time to time in the company's public announcements.
CONTACT:
Drew Milburn
info@galaglobalinc.com
(714) 660-3081
SOURCE: Gala Global, Inc.
